BillionToOne inc Stock

Biotech Evommune and diagnostics startup BillionToOne will begin trading today, with venture investors avid to see public markets fully embrace the sector again. Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering     BillionToOne... Read more